NEOS Investment Management LLC Grows Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

NEOS Investment Management LLC increased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 523.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,125 shares of the biotechnology company's stock after buying an additional 5,143 shares during the quarter. NEOS Investment Management LLC's holdings in Axon Enterprise were worth $3,640,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the company. DRW Securities LLC purchased a new position in Axon Enterprise during the 3rd quarter worth $291,000. The Manufacturers Life Insurance Company raised its stake in shares of Axon Enterprise by 0.6% during the third quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company's stock worth $17,440,000 after purchasing an additional 276 shares during the last quarter. Dai ichi Life Insurance Company Ltd lifted its holdings in shares of Axon Enterprise by 63.6% during the third quarter. Dai ichi Life Insurance Company Ltd now owns 3,646 shares of the biotechnology company's stock worth $1,457,000 after purchasing an additional 1,418 shares during the period. D.A. Davidson & CO. grew its position in Axon Enterprise by 0.3% in the 3rd quarter. D.A. Davidson & CO. now owns 12,622 shares of the biotechnology company's stock valued at $5,044,000 after buying an additional 44 shares during the last quarter. Finally, Quantbot Technologies LP purchased a new position in Axon Enterprise during the third quarter worth about $84,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Robert W. Baird raised their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a report on Friday, December 6th. TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a "buy" rating and a $700.00 target price on the stock. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research report on Monday, January 27th. Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Finally, Needham & Company LLC restated a "buy" rating and issued a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $604.67.

Axon Enterprise Trading Up 2.5 %

NASDAQ:AXON traded up $13.24 during mid-day trading on Tuesday, reaching $539.19. The company's stock had a trading volume of 132,051 shares, compared to its average volume of 807,317. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company's fifty day simple moving average is $588.26 and its two-hundred day simple moving average is $551.61. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a market cap of $41.31 billion, a P/E ratio of 139.33, a P/E/G ratio of 5.17 and a beta of 1.12.

Insiders Place Their Bets

In other news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company's stock, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.